First-in-man implantation of bioresorbable vascular scaffold in left internal mammary artery graft.
Bioresorbable vascular scaffold has many advantages over the metallic stent in the treatment of coronary stenotic lesions. It has added advantages in lesions that are close to the ostium of the culprit vessel, as in the left main coronary artery, right coronary artery, or left internal mammary artery, as in our case. As the hanging segments of the stent dissolve in 2 years, it reduces difficulty in engaging the vessel for future interventions if needed. To the best of our knowledge, this is the first case report of the Absorb bioresorbable vascular scaffold implanted in the left internal mammary artery from the left radial approach.